May 21 @ 11:30 am – 12:15 pm PDT
Innovation Theater 3
Supported By: Sanofi and Regeneron
Program Description
OCS are an important tool for the management of acute asthma symptoms but require regular risk-benefit assessment. Let’s discuss OCS use for our patients with uncontrolled moderate-to-severe asthma.
Speakers
Presenter: Brian A. Reichardt, MD, FCCP
Saint Elizabeth’s Hospital
Pulmonologist
O’Fallon, Illinois